Inna Perevozskaya

Statistics

Publications

Citations

1.6K

H-Index

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Tessella (United Kingdom)

University of Miami

National Research Institute

GlaxoSmithKline (United States)

Inna Perevozskaya is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology, and pharmacy.

Publications per year

2002–2021

Publications

Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans

Thomas Sudhop, Dieter Lütjohann, Annette Kodal et al. · Circulation · 2002 · 687 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia

Michel Farnier, Mason W. Freeman, Geraldine Macdonell et al. · European Heart Journal · 2005 · 162 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Bayesian Optimal Designs for Phase I Clinical Trials

Linda M. Haines, Inna Perevozskaya, William F. Rosenberger · Biometrics · 2003 · 119 citations

Public Health, Biostatistics, Pharmacology +15

Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia

Michel Farnier, Eli M. Roth, Blas Gil Extremera et al. · American Heart Journal · 2007 · 83 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Efficacy and safety of ezetimibe co‐administered with simvastatin in thiazolidinedione‐treated type 2 diabetic patients

Linda Gaudiani, Alex Lewin, Luigi Meneghini et al. · Diabetes Obesity and Metabolism · 2004 · 74 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 20